Analytical Studies

The National Prescription Drug Utilization Information System (NPDUIS) analyses drug price, utilization, and cost trends in Canada. Results of these analyses are published in the following reports.

Just Released New

NPDUIS CompassRx, 2nd edition – 2013/14 (May 2016) (PDF - 4.02 MB)

Generics360 – Generic Drugs in Canada, 2014 (February 2016) (PDF - 1.75 MB)

CompassRx

NPDUIS CompassRx, 1st Edition

NPDUIS CompassRx, 2nd Edition (May 2016) (PDF - 4.02 MB)

NPDUIS CompassRx, 1st Edition (March 2015) (PDF - 4,036 Kb)
Analysis Brief: NPDUIS CompassRx, 1st Edition (March 2015) (PDF - 804 Kb)

Generic Drugs

Generic360

Private Drug Plans

Private Drug Plans in Canada - Part 1: Generic Market 2005–2013

New Drug Pipeline Monitor

New Drug Pipeline Monitor

Other NPDUIS Studies

Other NPDUIS Studies

Presentations

Poster Presentations

Poster Presentations

Slide Presentations

Tamper-Resistant Properties of Drugs Regulations – Cost Impact Analysis, 2019 (September 2015) (PDF 1.22 MB)

Date modified: